Adverum Biotechnologies, Inc.: accounts_payable
| Value | {"amount": 4663000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2020-03-31) |
| Status | current |
| Entity | Adverum Biotechnologies, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:01:42.416243+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/516a53bf-dae3-47c1-b739-04a247c6f7e9
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-20-008534Retrieved: 2026-08-19T15:01:42.416243+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001501756/accounts-payable/2020-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/516a53bf-dae3-47c1-b739-04a247c6f7e9
History
- no predecessors — first report